![Tirzepatide,](/ProductImageEN1/2024-09/Large/09b58a92-7aec-47d0-8321-a72a32d6a402.jpg)
Tirzepatide, NEW
Price | Get Latest Price | ||
Package | 2MG | 5MG | 10MG |
Min. Order: | 1MG |
Supply Ability: | 100g |
Update Time: | 2024-09-04 |
Product Details
Product Name: Tirzepatide, | CAS No.: 2023788-19-2 |
Min. Order: 1MG | Purity: 99% |
Supply Ability: 100g | Release date: 2024/09/04 |
Tirzepatide Packaging available: 1mg, 2mg, 5mg, 10mg, 1g, 10g
CAS No.: 2023788-19-2
Molecular Weight:4813.45
Modify Date.: 2023-01-29 09:56
Introduction:
Tirzepatide, with the chemical formula C165H244N48O47S and the CAS number 2023788-19-2. Tirzepatide belongs to the class of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and glucose-dependent insulinotropic polypeptide receptor agonists (GIPRAs). It is a fusion protein that combines the properties of both GLP-1 and GIP, which play crucial roles in regulating glucose metabolism and appetite control. This unique combination allows Tirzepatide to offer enhanced therapeutic benefits compared to traditional treatments.Managing Type 2 Diabetes: Tirzepatide has shown remarkable efficacy in the management of type 2 diabetes mellitus. By stimulating the GLP-1 and GIP receptors, this drug helps regulate blood glucose levels, promote insulin secretion, and reduce glucagon release. It aids in improving glycemic control and may lead to weight loss, making it an attractive option for individuals with type 2 diabetes.Weight Management: Tirzepatide also demonstrates potential in weight management. Its dual action on appetite regulation and glucose metabolism can result in significant weight loss in individuals with obesity. By influencing satiety and energy expenditure, Tirzepatide offers a holistic approach to combating excess weight.Cardiovascular Benefits: Clinical trials have shown that Tirzepatide may have additional cardiovascular benefits. It has demonstrated the potential to reduce the risk of major cardiovascular events, such as heart attack and stroke, in individuals with type 2 diabetes and established cardiovascular disease. This makes Tirzepatide a valuable option for patients who require both glycemic control and cardiovascular risk management.Future Therapeutic Potential: Beyond its current applications, ongoing research on Tirzepatide explores its potential in other areas, such as non-alcoholic steatohepatitis (NASH), chronic kidney disease, and neurodegenerative disorders. These investigational uses highlight the versatility of this compound and its potential to revolutionize treatment approaches in the future.
Company Profile Introduction
Hangzhou Runyan Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the production and research and development of nucleotide and anti-virus products. The products are mainly used in pharmaceutical intermediates, veterinary drugs, food additives and other fields. After years of exploration and efforts, it has formed antiviral agents such as Oseltamivirphosphate, Remdesivir, Molnupiravir, Nirmatrelvir and other anti-virus products.And Cabozantinib Malate, Selpercatinib, Poziotinib and Isotinic Anti-Cancer pharmaceutical intermediates, polyinosinic-polycytidylic acid sodium salt, Adenosine Cyclophosphate , Uridine 5'-monophosphate disodium salt, Adenosine Triphosphate Disodium, Adenosine 5'-monophosphate, Adenosine and other nucleotides production and operation mode of nucleotide series products.
The enterprise has a sound operating mechanism, with a central laboratory, a 100000 level purification workshop meeting GMP standards, several intelligent computer controlled batching workshops, full-automatic product packaging lines and professional transport institutions, production equipment and internationally leading production technology.
Based on the principle of "moistening the world, beaming with joy", the company is constantly exploring the original road to achieve greater progress and development. We warmly welcome and look forward to common development and progress with customers at home and abroad!
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1g |
VIP1Y
|
Sichuan Tai Hui Biotechnology Co., Ltd
|
2024-08-29 | |
$500.00/1gram |
VIP1Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-08 | |
$0.00/1box |
VIP5Y
|
Jinan Jianfeng Chemical Co., Ltd
|
2024-08-07 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-08-02 | |
$1.00/1box |
VIP2Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2024-07-30 | |
$65.00/1Box |
VIP1Y
|
Qingdao Xinli Technology Development Co., Ltd.
|
2024-07-25 | |
$165.00/1box |
VIP1Y
|
Binzhou Lista Trading Limited
|
2024-07-02 | |
$20.00/10mg |
VIP2Y
|
Zhuzhou New Peptides Tech Co.,Ltd.
|
2024-06-20 | |
$5.00/5mg |
VIP1Y
|
Hebei Ganmiao New material Technology Co., LTD
|
2024-06-06 | |
$0.10/20mg |
VIP1Y
|
Shanghai Likang New Materials Co., Limited
|
2024-05-27 |
- Since: 2022-10-14
- Address: Room 530, 5F, building 10, Xintiandi business center, Gongshu District, Hangzhou City, Zhejiang Prov
INQUIRY
+86-18882027439
sales2@runyanpharma.com